Human clostridium tetani toxoid immune globulin
Package labels
Loading package label images…
Looking up MedlinePlus…
From MedlinePlus, U.S. National Library of Medicine
Dosing in kidney impairment
This label has no separate kidney-impairment dosing section. Check warnings and clinical pharmacology in the full label.
Preparation and administration
Prepare this dose
Your numbers for human clostridium tetani toxoid immune globulin. Take vial strength, diluent, and limits from the label below.
Enter a dose to see draw volume, final concentration, and rates.
The dosage should be adjusted according to the severity of the infection. (7,8) Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. They should not be used if particulate matter and/or discoloration are present. Hyper TET S/D is supplied with a syringe and an attached UltraSafe ® Needle Guard for your protection and convenience.
Drug interactions
Check interactions
Add the patient's other drugs. Matches come from both FDA labels: by name, drug class, and enzyme or transporter pathway.
- Human clostridium tetani toxoid immune globulin
Label text (1 paragraph)
Drug Interactions Antibodies in immunoglobulin preparations may interfere with the response to live viral vaccines such as measles, mumps, polio, and rubella. Therefore, use of such vaccines should be deferred until approximately 3 months after Tetanus Immune Globulin (Human) — Hyper TET TM S/D administration. No interactions with other products are known.
Contraindications
None known.
Safety data
Reported adverse events (FAERS)
Liver injury (LiverTox)
LiverTox has no chapter for human clostridium tetani toxoid immune globulin. Check the label's hepatic warnings.
Pregnancy and lactation
Pregnancy
Pregnancy Category C Animal reproduction studies have not been conducted with Hyper TET S/D. It is also not known whether Hyper TET S/D can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Hyper TET S/D should be given to a pregnant woman only if clearly needed.
For breastfeeding, also see LactMed (National Library of Medicine), which summarizes milk levels and infant effects.
Supply and cost
Drug shortage status
Recalls (last 24 months)
Therapeutic equivalence (Orange Book)
Price ladder
Not the price at the counterThese are not what a patient pays at the pharmacy counter. They are what pharmacies, health plans, and government buyers pay, before manufacturer rebates. A patient's cost depends on their insurance (copay, coinsurance, or deductible) or the pharmacy's cash price.